Discover predictive biomarkers for your therapy
Pharma R&D costs are soaring and you’re facing a longer and longer drug development cycle. You want to know as soon as possible which drugs would fail for a particular indication so that you can dodge a bullet and not waste time/money down the pipeline. Or, you want to repurpose a drug candidate by finding suitable target biomarkers.
We combine patient-derived tumors with microfluidic chips to model cancer progression, including metastasis, in real time to find potential therapeutics or targets.